The clonoSEQ® Watch Registry
About the study
This is a prospective, multicenter, observational study of adult patients with a diagnosis of acute lymphoblastic leukemia (ALL), multiple myeloma (MM), chronic lymphocytic leukemia (CLL), or non-Hodgkin lymphoma (NHL). This study will enroll up to 528 patients in up to 50 sites in the United States and collect data with regard to use of the clonoSEQ MRD assay in the management of lymphoid malignancies.
Who can take part
You may be eligible to participate in the study if you meet the following criteria:
INCLUSION CRITERIA
Inclusion Criteria:
- Patients must be able to provide written informed consent
- A decision has been made by the treating provider to use the clonoSEQ Assay as part of routine clinical care
- Age ≥ 18 years;
Documented hematologic malignancy (any of the below):
- MM
- ALL (B and T-cell subtypes)
- B-cell NHL (all sub types)
- CLL
- Other lymphoid malignancies (upon review and approval by study chair)
EXCLUSION CRITERIA
Exclusion Criteria:
Patients must not meet any of the following criteria in order to be enrolled into the study:
- Concurrent enrollment in a clinical trial where treatment decisions and patterns are dictated per protocol
- A decision has been made by the treating provider to not use the clonoSEQ Assay as part of routine clinical care
Study Locations
Enter your ZIP code/Postal code/PIN code to locate study sites near you:
How to Apply
Contact the study center to learn if this study is a good match for you.
Study’s details
Contition
Non-hodgkin Lymphoma,Acute Lymphoblastic Leukemia, Adult B-Cell,Chronic Lymphocytic Leukemia,Multiple Myeloma
Age (in years)
18+
Participants needed
528
Est. Completion Date
Dec 31, 2024
Treatment type
Observational [Patient Registry]
Sponsor
Adaptive Biotechnologies
ClinicalTrials.gov identifier
NCT04545333
Study number
ADAP-008
Understanding Clinical Trials
Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?